Future Tech

    Engineered “mini livers” could be injected as an alternative to transplantation

    Researchers develop injectable mini livers to treat chronic disease without traditional organ transplantation.

    A technology developed by Professor Sangeeta Bhatia, SM ’93, PhD ’97, and colleagues could offer new hope to the thousands of Americans with chronic liver disease who are waiting for an organ transplant or not strong enough to tolerate one. The liver is involved in regulating blo...

    MTR

    MIT Technology Review

    Source

    MIT Technology ReviewRead the full story at MIT Technology Review
    Engineered “mini livers” could be injected as an alternative to transplantation
    AI Analysis

    Generated insight by OnAirToday AI

    This breakthrough leverages regenerative medicine to bypass the severe organ shortage crisis and the risks associated with major transplant surgery. By enabling localized liver function through injection, this technology could fundamentally transform how we treat end-stage organ failure.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at MIT Technology Review →

    Get the day's AI news in one short email. Free.

    Share

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000

    Subscribe to our Free AI Newsletter

    The Daily AI Digest, every morning. Pick your topics after you subscribe.

    Free. Unsubscribe anytime.